Litera Firm Intelligence Business Unit Cements Strategic Partnership with Wilson Allen
29.6.2021 16:00:00 EEST | Business Wire | Press release
The Litera Firm Intelligence business unit, developer of the Foundation data platform, and Wilson Allen, a leading provider of software, services, and consulting expertise to help law firms manage the entire client engagement lifecycle, today announced a strategic partnership. The partnership formalizes Wilson Allen as a technical implementation partner for the Foundation Firm Intelligence platform.
The Foundation Firm Intelligence platform breaks down data silos, combining information from disparate systems like CRM, Time and Billing, HR, conflicts, and external sources to provide a strategic view of law firm clients, including what work a firm has done for a client, who did the work, and all the third parties involved.
As a Foundation services partner, Wilson Allen will assist firms with implementing the Firm Intelligence platform and with associated strategic consulting, integration services, and data management services as needed.
“We’ve talked to several firms who are moving beyond the acronym of CRM when implementing solutions to better understand their client relationships across the client and matter lifecycle. Firm intelligence fits into a larger definition of business development strategy,” explained Michael Warren, Vice President and head of Wilson Allen’s Client Development and Intake practice. “Helping these firms implement Foundation is a natural fit for Wilson Allen, given our deep experience advising law firms on how to leverage their systems and data for competitive advantage. The company’s client development practice assists firms with software selection, data strategy and data migration, software implementation, technology training and change management.
“We’re seeing a growing need for business development and CRM expertise as firms move to leverage their Firm Intelligence platform for strategic relationship management,” said Barry Solomon, Litera Vice President for the Firm Intelligence business unit. “We are thrilled to partner with Wilson Allen to lead these Foundation projects. Michael Warren and his team bring tremendous depth and breadth across the business development domain and other system data and processes required to accelerate the business of law.”
About Litera Firm Intelligence Business Unit
Litera is the leading provider of software for law firms and document-intensive organizations across the globe, helping them satisfy the demands of clients. Part of the Firm Intelligence business unit, Foundation enables large law firms to transform their disparate data about clients, matters, people, and parties into usable and actionable information. The Foundation data platform includes integrated applications for Experience Management, Expertise Location, and Strategic Relationship Management – leveraging firm knowledge to win new business, improve client service, and gain insight into both the business and practice of law.
https://www.litera.com/
About Wilson Allen
Wilson Allen offers software, consulting, and technical services that enable law firms and professional services organizations to achieve better business performance. The company partners with leading industry solution providers to help firms identify and win more business, manage risk, deliver profitable engagements, and develop and implement performance analytics to enable more strategic and profitable operations.
https://wilsonallen.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210629005602/en/
Contact information
Media
Litera, Firm Intelligence Business Unit
Nancy Baron
E: Nancy.Baron@FoundationSG.com
Wilson Allen
Matthew DeVoll
E: Matthew.Devoll@WilsonAllen.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
Seoul Viosys Eyes the $60 Billion AI Data Center Optical Communication Market with Opto Semiconductors27.4.2026 16:00:00 EEST | Press release
Seoul Viosys (KOSDAQ: 092190), a company specializing in opto-semiconductor devices, is accelerating its entry into the next-generation photonics market supported by its proprietary “No-wire” and “No-package” fundamental patents—essential technologies for micrometer (μm)-scale miniaturization of opto-semiconductors—as well as its competitiveness in VCSEL technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426926495/en/ Seoul Viosys Optoelectronic Semiconductor Structure Subject to a Permanent U.S. Injunction in February 2026, Covering Similar Products and Employees (Image: Seoul Viosys) As the rapid expansion of AI drives a paradigm shift in data centers from copper-based to optical-based architectures, the company is strengthening its position through the acquisition of a VCSEL company for short-range communications five years ago and the completion of 100G (25G×4) class technology. Furthermore, Seoul Viosys is ex
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom